AREGEN

Serial Number 75765133
606

Registration Progress

Application Filed
Aug 24, 1999
Under Examination
May 30, 2000
Approved for Publication
Jan 21, 2000
Published for Opposition
Feb 22, 2000
Registered

Trademark Image

AREGEN

Basic Information

Serial Number
75765133
Filing Date
August 24, 1999
Published for Opposition
February 22, 2000
Abandonment Date
May 31, 2003
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 31, 2003
Classes
005

Rights Holder

Novartis AG

03
Address
CH-4002
Basel
CH

Ownership History

Novartis AG

Original Applicant
03
Basel CH

Novartis AG

Owner at Publication
03
Basel CH

Legal Representation

Attorney
Barry A. Solomon

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

19 events
Date Code Type Description Documents
Aug 7, 2003 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 27, 2003 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 18, 2002 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 1, 2002 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 18, 2002 PETG O PETITION TO REVIVE-GRANTED Loading...
Nov 30, 2001 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 24, 2001 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 24, 2001 EXT3 S SOU EXTENSION 3 FILED Loading...
May 8, 2001 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 8, 2001 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 26, 2001 PETR I PETITION TO REVIVE-RECEIVED Loading...
Mar 31, 2001 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Nov 30, 2000 EXT1 S SOU EXTENSION 1 FILED Loading...
May 30, 2000 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 17, 2000 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Feb 22, 2000 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 21, 2000 NPUB O NOTICE OF PUBLICATION Loading...
Nov 8, 1999 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 5, 1999 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for use in the field of oncology
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005